ES2061982T3 - Activador de plasminogeno y agente trombolitico. - Google Patents

Activador de plasminogeno y agente trombolitico.

Info

Publication number
ES2061982T3
ES2061982T3 ES89303742T ES89303742T ES2061982T3 ES 2061982 T3 ES2061982 T3 ES 2061982T3 ES 89303742 T ES89303742 T ES 89303742T ES 89303742 T ES89303742 T ES 89303742T ES 2061982 T3 ES2061982 T3 ES 2061982T3
Authority
ES
Spain
Prior art keywords
staphylokinase
plasminogen activator
thrombolytic agent
agent
plasminogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89303742T
Other languages
English (en)
Other versions
ES2061982T5 (es
Inventor
Masashi C O Kabushiki Ka Sakai
Osamu Matsuo
Masaaki Kabushiki Kai Watanuki
Toshizo Kabushiki Kais Sakurai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26348760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2061982(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP63090252A external-priority patent/JP2707273B2/ja
Priority claimed from JP1013044A external-priority patent/JP2627950B2/ja
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Publication of ES2061982T3 publication Critical patent/ES2061982T3/es
Application granted granted Critical
Publication of ES2061982T5 publication Critical patent/ES2061982T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

AGENTE TROMBOLITICO QUE CONTIENE ESTAFILOQUINASA COMO INGREDIENTE ACTIVO; LA ESTAFILOQUINASA ES UN ACTIVADOR DE PLASMINOGENO PRODUCIDO POR EL STAPHYLOCOCCUS AUREUS. EL AGENTE SE PUEDE EMPLEAR TERAPEUTICAMENTE EN EL TRATAMIENTO DE ENFERMEDADES TROMBOSICAS TALES COMO INFARTO DE MIOCARDIO Y ESCLEROSIS ARTERIAL. EL AGENTE TROMBOLITICO TIENE UN TIEMPO DE RETARDO MEJORADO A CONCENTRACIONES ALTAS POR FORMACION DE UN COMPLEJO ENTRE ESTAFILOQUINASA Y PLASMINOGENO (O PLASMINA).
ES89303742T 1988-04-14 1989-04-14 Activador de plasminogeno y agente trombolitico. Expired - Lifetime ES2061982T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63090252A JP2707273B2 (ja) 1988-04-14 1988-04-14 血栓溶解剤
JP1013044A JP2627950B2 (ja) 1989-01-24 1989-01-24 プラスミノーゲンアクチベータ及び血栓溶解剤

Publications (2)

Publication Number Publication Date
ES2061982T3 true ES2061982T3 (es) 1994-12-16
ES2061982T5 ES2061982T5 (es) 1999-03-16

Family

ID=26348760

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89303742T Expired - Lifetime ES2061982T5 (es) 1988-04-14 1989-04-14 Activador de plasminogeno y agente trombolitico.

Country Status (5)

Country Link
EP (1) EP0337817B2 (es)
KR (1) KR0135980B1 (es)
CA (1) CA1339211C (es)
DE (1) DE68912383T3 (es)
ES (1) ES2061982T5 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5475089A (en) * 1990-12-17 1995-12-12 Kabushiki Kaisha Yakult Honsha Thrombolytic peptide, production thereof, and thrombolytic agent
ATE147989T1 (de) * 1991-06-28 1997-02-15 Leuven Res & Dev Vzw Verwendung von staphylokinase für die herstellung einer zusammensetzung für die behandlung von gefässthrombose
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5867181A (ja) * 1981-10-16 1983-04-21 Yakult Honsha Co Ltd スタフイロキナーゼ産生遺伝情報を担うｄｎａ断片組み換え体ｄｎａおよびそれを導入した大腸菌

Also Published As

Publication number Publication date
DE68912383T3 (de) 1999-06-02
KR900015752A (ko) 1990-11-10
EP0337817A2 (en) 1989-10-18
DE68912383D1 (de) 1994-03-03
ES2061982T5 (es) 1999-03-16
EP0337817A3 (en) 1990-08-29
KR0135980B1 (ko) 1998-04-25
CA1339211C (en) 1997-08-05
EP0337817B2 (en) 1998-12-16
DE68912383T2 (de) 1994-07-14
EP0337817B1 (en) 1994-01-19

Similar Documents

Publication Publication Date Title
ATE101524T1 (de) Hirudin und aktivator des plasminogens enthaltende pharmazeutische wirksame verbindung.
ES2062662T3 (es) Composiciones de blanqueo a baja temperatura.
DE69033570D1 (de) Topische Zusammensetzungen, die LYCD und sonstige topische aktive Mittel enthalten
ES2052682T3 (es) Una composicion farmaceutica potenciadora de la penetracion para aplicacion topica.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
FR2328039A1 (fr) Concentres stables de detergent liquide contenant de l'oxygene actif
IT1036863B (it) Fosfordtioato alogenato fingicida procedimento per la sua produzione e composizione fungicide che lo contengono come agente attivo
SE8103925L (sv) Acne-behandling
FR1419437A (fr) Concentrés liquides contenant de l'oxygène actif et possédant des propriétés tensioactives
SE8701921D0 (sv) Ny farmaceutisk anvendning
SE8301795D0 (sv) Plasminogenaktivatorkomplex
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ES428715A1 (es) Procedimiento para la obtencion de un medio para el blan- queo y el tenido del cabello.
ES2061982T3 (es) Activador de plasminogeno y agente trombolitico.
CH432541A (fr) Procédé de préparation d'agents tensio-actifs amphotères
ES404616A1 (es) Procedimiento para la obtencion de una composicion con ac- tividad anti-seborreica y de uso externo.
IT8068733A0 (it) Procedimento per la preparazione di attivatori di plasminogeni utili come agenti terapeutici e diagnostici
BE860162A (fr) Derives actifs de l'uree leur procede de preparation ainsi que les compositions therapeutiques les contenant
KR880007731A (ko) 하이브리드 단백질
ES2042553T3 (es) Un proceso para la preparacion de un activador del plasminogeno fibrinoliticamente activo.
AR213258A1 (es) Composicion fungicida que comprende como agente activo,acido 3-(3',5'-diclorofenilcarbamoil)-norbornan o 7-oxabiciclo(2,3,1)-heptan-2 carboxilico o n-(3' 5'-diclorofenil)-norbornan-2,3-carbocamidalico o n-(3',5'-diclorofenil)-norbornan-2,3-carbocamida
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
HU171992B (hu) Insekticidnye, akaricidnye i nematocidnye kompozicija soderzhahhie slozhnye efiry i efiramidy 0-triazolil-skobka-tiono-skobka zakryta-fosfornojj-, skobka-fosfonnojj-ili fosfinnojj-skobka zakryta-kislot, i sposob poluchenija aktivnykh agentov
JPS5262317A (en) Shampoo composition with reduced irritation
JPS5399086A (en) Surfactant composition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 337817

Country of ref document: ES